Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Erythema
(1999): Alexiou C+, Laryngorhinootologie (German) 78, 573
(1998): Valsecchi R+, Contact Dermatitis 38(6), 362
(1995): Saff DM+, Arch Dermatol 131, 742 (localized)
Exanthems
(1995): Ijsselmuiden O+, Acta Derm Venereol (Stockh) 75, 57
Fixed eruption
(2001): Sener O+, Ann Allergy Asthma 86(3), 335
Necrosis
(1999): Ostergaard M+, Ugeskr Laeger 161(5), 582
Pigmentation
(2004): Gallardo MJ+, Am J Ophthalmol 137(4), 779
(2002): Evans AV+, Clin Exp Dermatol 27(3), 247
(1998): Kumar P+, Burns 24(5), 487
(1996): Ritota PC+, Ann Plast Surg 36(5), 508
Pruritus
(1995): Saff DM+, Arch Dermatol 131, 742 (localized)
Rash (sic)
Thinning
(2003): Fesq H+, Br J Dermatol 149(3), 611
Urticaria
(1995): Ijsselmuiden OE+, Acta Derm Venereol 75, 57
Mucosal
Mucosal irritation
(2000): Gawchik SM+, Drug Saf 23(4), 309
Xerostomia
(1995): Loesche WJ+, JAmGeriatrSoc43(4), 401
Eyes
Cataract
(2005): Cekic O+, Am J Ophthalmol 139(6), 993
(2005): Gillies MC+, Ophthalmology 112(1), 139
(2005): Jonas JB+, Eur J Ophthalmol 15(4), 462
(2005): Kuo HK+, Chang Gung Med 28(2), 85 (13%)
(2004): Ciardella AP+, Br J Ophthalmol 88(9), 1131
(2004): Jaissle GB+, Ophthalmologe 101(2), 121
(2004): Jonas JB+, Ophthalmologe 101(2), 113
(2004): Lang GE, Ophthalmologe 101(12), 1165
(2003): Jonas JB+, Klin Monatsbl Augenheilkd 220(6), 384
(2003): Rechtman E+, Am J Ophthalmol 136(4), 739
(2001): Young S+, Clin Experiment Ophthalmol 29(1), 2
(1998): Challa JK+, Aust N Z J Ophthalmol 26(4), 277
Chorioretinopathy
(2005): Imasawa M+, Acta Ophthalmol Scand 83(1), 132
Conjunctival ulceration
(2004): Jaissle GB+, Ophthalmologe 101(2), 121
(2003): Agrawal S+, Am J Ophthalmol 136(3), 539
Endophthalmitis
(2005): Moshfeghi DM+, Ophthalmic Surg Lasers 36(1), 24
(2005): Westfall AC+, Arch Ophthalmol 123(8), 1075 (0.1%)
(2004): Chen SD+, Arch Ophthalmol 122(11), 1733
(2004): Jaissle GB+, Ophthalmologe 101(2), 121
(2004): Jonas JB+, Ophthalmologe 101(2), 113
(2004): Lang GE, Ophthalmologe 101(12), 1165
(2004): Sutter FK+, Ophthalmology 111(11), 2044
(2004): Yamashita T+, Graefes Arch Clin Exp Ophthalmol
242(8), 679
(2003): Benz MS+, Arch Ophthalmol 121(2), 271
(2003): Jonas JB+, Klin Monatsbl Augenheilkd 220(6), 384
(2003): Nelson ML+, Retina 23(5), 686
(2003): Roth DB+, Arch Ophthalmol 121(9), 1279
(2003): Sutter FK+, Br J Ophthalmol 87(8), 972
Eyelid pigmentation
(2004): Gallardo MJ+, Am J Ophthalmol 137(4), 779
Glaucoma
(2005): Agrawal S+, Am J Ophthalmol 139(3), 575
(2005): Kuo HK+, Chang Gung Med J 28(2), 85 (23%)
(2004): Jaissle GB+, Ophthalmologe 101(2), 121
(2004): Kaushik S+, Am J Ophthalmol 137(4), 758
TRIAMCINOLONE 555
(2004): Levy J+, Can J Ophthalmol 39(6), 672
(2003): Jonas JB+, Arch Ophthalmol 121(5), 729
Ocular edema
(2003): Mackiewicz J+, Ann Univ Mariae Curie Sklodowska [Med]
58(1), 158
Ocular hypertension
(2005): Kuo HK+, Chang Gung Med J 28(2), 85 (77%)
(2004): Degenring RF+, Ophthalmologe 101(3), 251 (31%)
(2004): Detry-Morel M+, Bull Soc Belge Ophtalmol l(292), 45
(2004): Jonas JB+, Ophthalmologe 101(2), 113 (40%)
Ocular pressure
(2005): Jonas JB+, Ophthalmology 112(4), 593
(2005): Kreissig I+, Ophthalmologe 102(2), 153
(2005): Vedantham V, Am J Ophthalmol 139(3), 575
(2004): Agrawal S+, Am J Ophthalmol 138(4), 679
(2004): Ciardella AP+, Br J Ophthalmol 88(9), 1131
(2004): Ferrante P+, Clin Experiment Ophthalmol 32(6), 563
(2004): Gillies MC+, Arch Ophthalmol 122(3), 336
(2004): Lang GE, Ophthalmologe 101(12), 1165
(2004): Lee AC+, Semin Ophthalmol 19(3-4), 119
(2004): Singh IP+, Am J Ophthalmol 138(2), 286
(2004): Smithen LM+, Am J Ophthalmol 138(5), 740
(2003): Bakri SJ+, Ophthalmic Surg Lasers Imaging 34(5), 386
(2003): Jonas JB+, Br J Ophthalmol 87(1), 24
(2003): Jonas JB+, Klin Monatsbl Augenheilkd 220(6), 384 (50%)
(2003): Rechtman E+, Am J Ophthalmol 136(4), 739
(2002): Bui Quoc E+, JFrOphtalmol25(10), 1048
(2001): Young S+, Clin Experiment Ophthalmol 29(1), 2
(1999): Wingate RJ+, Aust N Z Ophthalmol 27(6), 431
(1998): Challa JK+, Aust N Z Ophthalmol 26(4), 277
(1996): Akduman L+, Am J Ophthalmol 122(2), 275
(1995): Helm CJ+, Am J Ophthalmol 120(1), 55
(1995): Kalina PH+, Arch Ophthalmol 113(7), 867
Ptosis
(2005): Dal Canto AJ+, Ophthalmology 112(6), 1092
(2004): Ferrante P+, Clin Experiment Ophthalmol 32(6), 563
Retinal detachment
(2004): Jaissle GB+, Ophthalmologe 101(2), 121
Uveitis
(2005): Cano Parra J+, Arch Soc Esp Oftalmol 80(3), 137
Vision impaired
(2004): Moshfeghi AA+, Am J Ophthalmol 138(3), 489
(2004): Sharma MC+, Cornea 23(4), 398
(2002): Moshfeghi DM+, Am J Ophthalmol 134(1), 132
Other
Anaphylactoid reactions/Anaphylaxis
(2003): Karsh J+, Ann Allergy Asthma Immunol 90(2), 254
(2000): Alexander J, Tulsa, OK (from Internet) (observation)
(2000): Vedamurthy M, Chennai, India (from Internet)
(observation)
(1998): Downs AM+, Arch Dermatol 134(9), 1163
Cough
(1998): Berkowitz R+, Chest 114(3), 757
Hypersensitivity
(2000): Brancaccio RR+, Cutis 65, 31
Injection-site lipoatrophy
(2002): Cleary JD, Ann Pharmacother 36(4), 726
(2000): Anderson B+, Arch Intern Med 151, 153
(2000): Breit W+, J Rheumatol 27(11), 2696
Injection-site necrosis (avascular)
(2001): Nasser SM+, BMJ 322(7302), 1589
Moon face
(2002): Jansen TL+, Neth J Med 60(3), 151
(2002): Teelucksingh S+, Ann Trop Paediatr 22(1), 89
Myalgia/Myositis/Myopathy/Myotoxicity
(1995): Boonen S+, Br J Rheumatol 34(4), 385
Pain
(2004): Jirarattanaphochai K+, J Bone Joint Surg Am 86(12), 2700